Emerald Mutual Fund Advisers Trust’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,408
| Closed | -$593K | – | 212 |
|
|
2024
Q4 | $593K | Sell |
19,408
-230,096
| -92% | -$7.4M | 0.04% | 153 |
|
|
2024
Q3 | $7M | Sell |
249,504
-5,737
| -2% | -$141K | 0.36% | 88 |
|
|
2024
Q2 | $5.81M | Sell |
255,241
-16,573
| -6% | -$383K | 0.3% | 96 |
|
|
2024
Q1 | $8.27M | Sell |
271,814
-90,545
| -25% | -$3.03M | 0.43% | 89 |
|
|
2023
Q4 | $12.9M | Sell |
362,359
-49,041
| -12% | -$1.82M | 0.68% | 61 |
|
|
2023
Q3 | $18M | Hold |
411,400
| – | – | 1.09% | 30 |
|
|
2023
Q2 | $20.3M | Hold |
411,400
| – | – | 1.1% | 31 |
|
|
2023
Q1 | $17.1M | Buy |
411,400
+5,700
| +1% | +$237K | 1.01% | 35 |
|
|
2022
Q4 | $18M | Buy |
405,700
+56,620
| +16% | +$2.37M | 1.12% | 32 |
|
|
2022
Q3 | $13.6M | Sell |
349,080
-28,259
| -7% | -$1.29M | 0.86% | 47 |
|
|
2022
Q2 | $15.4M | Buy |
377,339
+18,673
| +5% | +$884K | 0.89% | 40 |
|
|
2022
Q1 | $23.6M | Sell |
358,666
-79,313
| -18% | -$5.14M | 1.04% | 33 |
|
|
2021
Q4 | $30.5M | Sell |
437,979
-49,483
| -10% | -$3.6M | 1.07% | 36 |
|
|
2021
Q3 | $33.9M | Sell |
487,462
-52,394
| -10% | -$4.03M | 1.17% | 29 |
|
|
2021
Q2 | $42.8M | Hold |
539,856
| – | – | 1.4% | 14 |
|
|
2021
Q1 | $35.4M | Buy |
539,856
+21,820
| +4% | +$1.34M | 1.17% | 19 |
|
|
2020
Q4 | $28.8M | Buy |
518,036
+40,972
| +9% | +$1.77M | 1% | 29 |
|
|
2020
Q3 | $19M | Sell |
477,064
-19
| -0% | -$806 | 0.84% | 48 |
|
|
2020
Q2 | $21.4M | Buy |
477,083
+60,431
| +15% | +$2.63M | 1.01% | 31 |
|
|
2020
Q1 | $14M | Sell |
416,652
-17,260
| -4% | -$621K | 0.88% | 39 |
|
|
2019
Q4 | $14.1M | Hold |
433,912
| – | – | 0.58% | 69 |
|
|
2019
Q3 | $10.8M | Hold |
433,912
| – | – | 0.48% | 76 |
|
|
2019
Q2 | $12.9M | Hold |
433,912
| – | – | 0.51% | 73 |
|
|
2019
Q1 | $11.6M | Hold |
433,912
| – | – | 0.47% | 74 |
|
|
2018
Q4 | $13.3M | Hold |
433,912
| – | – | 0.62% | 54 |
|
|
2018
Q3 | $15.2M | Buy |
433,912
+5,990
| +1% | +$190K | 0.51% | 79 |
|
|
2018
Q2 | $11.6M | Hold |
427,922
| – | – | 0.42% | 95 |
|
|
2018
Q1 | $8.78M | Sell |
427,922
-61,184
| -13% | -$1.1M | 0.34% | 110 |
|
|
2017
Q4 | $8.92M | Sell |
489,106
-10,084
| -2% | -$200K | 0.35% | 103 |
|
|
2017
Q3 | $11.2M | Buy |
499,190
+14,147
| +3% | +$320K | 0.47% | 79 |
|
|
2017
Q2 | $11.8M | Hold |
485,043
| – | – | 0.51% | 71 |
|
|
2017
Q1 | $9.29M | Hold |
485,043
| – | – | 0.42% | 85 |
|
|
2016
Q4 | $9.49M | Sell |
485,043
-25,000
| -5% | -$453K | 0.45% | 79 |
|
|
2016
Q3 | $8.07M | Sell |
510,043
-12,131
| -2% | -$186K | 0.41% | 94 |
|
|
2016
Q2 | $7.38M | Sell |
522,174
-271,540
| -34% | -$4.14M | 0.41% | 93 |
|
|
2016
Q1 | $13.4M | Sell |
793,714
-6,840
| -0.9% | -$120K | 0.75% | 50 |
|
|
2015
Q4 | $18M | Buy |
800,554
+194,135
| +32% | +$4M | 0.95% | 29 |
|
|
2015
Q3 | $13.3M | Buy |
606,419
+151,207
| +33% | +$3.78M | 0.87% | 36 |
|
|
2015
Q2 | $11.2M | Buy |
455,212
+128,079
| +39% | +$2.86M | 0.87% | 40 |
|
|
2015
Q1 | $6.69M | Buy |
327,133
+75,774
| +30% | +$1.47M | 0.55% | 70 |
|
|
2014
Q4 | $5.02M | Buy |
251,359
+32,879
| +15% | +$564K | 0.44% | 82 |
|
|
2014
Q3 | $3.22M | Buy |
218,480
+53,460
| +32% | +$852K | 0.31% | 104 |
|
|
2014
Q2 | $3.03M | Buy |
165,020
+52,050
| +46% | +$866K | 0.28% | 105 |
|
|
2014
Q1 | $2.13M | Buy |
+112,970
| New | +$2.31M | 0.2% | 117 |
|
Other funds holding ATRC
HRCM
CIP
FLAM
Emerald Mutual Fund Advisers Trust's ATRC Position: Q1 2025 in Review
Emerald Mutual Fund Advisers Trust sold out of AtriCure (ATRC) in Q1 2025, closing a stake of 19,408 shares — an estimated $593K sold.
Emerald Mutual Fund Advisers Trust first reported a position in ATRC in Q1 2014 and held it in 44 quarters. The position peaked at $42.8M in Q2 2021. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.
- Emerald Mutual Fund Advisers Trust reported no remaining AtriCure position as of Q1 2025 after selling out during the quarter.
- Emerald Mutual Fund Advisers Trust sold 19,408 AtriCure shares in Q1 2025, an estimated $593K.
- Emerald Mutual Fund Advisers Trust first reported a position in AtriCure in Q1 2014 and held it in 44 quarters.
- Emerald Mutual Fund Advisers Trust's AtriCure position peaked at $42.8M in Q2 2021.
- 221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2025, filed 1 May 2025.